Yahoo Web Search

Search results

1. • 

     Nutrition for Today: Weight loss ingredient Semaglutide, found in Ozempic, Wegovy, Rybelsus

     Florida Today via Yahoo News· 6 months ago

     The newest weight loss fad isn’t a diet this time — it’s a drug. Semaglutide, to be specific....

2. • 

     Is It Time to Take Some Gains in Novo Nordisk Stock? Not So Fast.

     Motley Fool· 9 months ago

     When it comes to investing in modern medicine, one area experiencing rising popularity is the global...

3. • 

     Interested in the Weight-Loss Market? Here's 1 Stock to Buy Hand Over Fist in 2024, and 1 to Avoid...

     Motley Fool via Yahoo Finance· 5 months ago

     When it comes to the pharmaceutical industry, weight-loss medications are all the rage right now....

4. • 

     Novo Nordisk Has More Than Ozempic. One of Its Other Treatments Grew 393% Last Year.

     Motley Fool via Yahoo Finance· 3 months ago

     Novo Nordisk (NYSE: NVO), a Danish pharmaceutical company, is the developer of Ozempic, which is...

5. • 

     These 2 Unstoppable Stocks Could Make You Richer in 2024 and Beyond

     Motley Fool via Yahoo Finance· 5 months ago

     Although one of the top investment themes of 2023 was artificial intelligence (AI), there were...

6. • 

     Is it Too Late to Buy Viking Therapeutics Stock?

     Motley Fool via Yahoo Finance· 2 months ago

     One of the hottest areas of the pharmaceutical industry right now is the weight loss treatment space. Novo Nordisk and Eli Lilly have been the primary...

7. • 

     Novo Nordisk and Eli Lilly May Finally Have Some Real Competition

     Motley Fool via Yahoo Finance· 2 months ago

     One of the biggest themes in the pharmaceutical market right now is weight-loss treatments. Demand...

8. • 

     Best Obesity Drug Stock: Eli Lilly, Novo Nordisk, or Viking Therapeutics?

     Motley Fool via Yahoo Finance· 2 months ago

     Some investors might remember the obesity drugs developed by Arena Pharmaceuticals and Vivus...

9. • 

     Eli Lilly Just Got One Step Closer to Dethroning Ozempic. Time to Buy the Stock?

     Motley Fool· 6 months ago

     Just about every evening when I sit down for dinner and turn on the television, a series of...

10. • 

      Move Over, Novo Nordisk -- This Is the Pharmaceutical Company I am Most Bullish On in 2024

      Motley Fool via Yahoo Finance· 4 months ago

      One of the biggest investment themes in 2023 stemmed from the popularity of a new class of obesity...